Literature DB >> 21373231

An unusual presentation and etiology of hypotension seen in nephrotic syndrome.

Anna-Maria Panagiotides, Aviv Hever, John J Sim.   

Abstract

Entities:  

Year:  2009        PMID: 21373231      PMCID: PMC3034432          DOI: 10.7812/TPP/08-084

Source DB:  PubMed          Journal:  Perm J        ISSN: 1552-5767


× No keyword cloud information.
  6 in total

1.  Quantitative serum free light chain assay in the diagnostic evaluation of AL amyloidosis.

Authors:  Harun Akar; David C Seldin; Barbarajean Magnani; Carl O'Hara; John L Berk; Christopher Schoonmaker; Howard Cabral; Laura M Dember; Vaishali Sanchorawala; Lawreen H Connors; Rodney H Falk; Martha Skinner
Journal:  Amyloid       Date:  2005-12       Impact factor: 7.141

Review 2.  Amyloidosis-associated kidney disease.

Authors:  Laura M Dember
Journal:  J Am Soc Nephrol       Date:  2006-11-08       Impact factor: 10.121

Review 3.  Light-chain (AL) amyloidosis: diagnosis and treatment.

Authors:  Vaishali Sanchorawala
Journal:  Clin J Am Soc Nephrol       Date:  2006-10-11       Impact factor: 8.237

4.  Primary systemic amyloidosis: clinical and laboratory features in 474 cases.

Authors:  R A Kyle; M A Gertz
Journal:  Semin Hematol       Date:  1995-01       Impact factor: 3.851

5.  Vascular abnormalities in primary amyloidosis.

Authors:  Karen M Modesto; Angela Dispenzieri; Morie Gertz; Sanderson A Cauduro; Bijoy K Khandheria; James B Seward; Robert Kyle; Christina M Wood; Kent R Bailey; Abdel Jamil Tajik; Fletcher A Miller; Patricia A Pellikka; Theodore P Abraham
Journal:  Eur Heart J       Date:  2007-04-12       Impact factor: 29.983

6.  High-dose melphalan and autologous stem-cell transplantation in patients with AL amyloidosis: an 8-year study.

Authors:  Martha Skinner; Vaishali Sanchorawala; David C Seldin; Laura M Dember; Rodney H Falk; John L Berk; Jennifer J Anderson; Carl O'Hara; Kathleen T Finn; Caryn A Libbey; Janice Wiesman; Karen Quillen; Niall Swan; Daniel G Wright
Journal:  Ann Intern Med       Date:  2004-01-20       Impact factor: 25.391

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.